1. Pink Sheet
  2. >>Archive

FDA Rx Risk Assessment Guidance May Detail Lab Test Parameters

 
• By The Pink Sheet

FDA's risk assessment working group is considering developing specific recommendations on which lab test results could signal safety problems for drugs under review

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from Pink Sheet